ACT-AD Chairman Daniel Perry Interviewed by BioCentury This Week

ACT-AD Chairman Daniel Perry is interviewed by BioCentury This Week to share his impressions on the fifth reauthorization of the Food and Drug Administration’s (FDA) Prescription Drug User Fee program (PDUFA). During the interview, Mr. Perry commends Congress for giving ACT-AD members and other active patient group, the ability to lend an early voice in shaping how user fees might be employed to help speed the delivery of better treatments and cures to patients in need of relief from a multitude of diseases including Alzheimer’s.